Loading company…
METADX develops AI tools and diagnostic services for veterinary medicine.
METADX develops AI-based veterinary products, including CancerVET™ for detecting pet tumors from serum biomarkers and VitalVET™ for monitoring anesthesia. It also offers TraceVET™, a referral testing service using a central laboratory. Based in Seoul, South Korea, the company raised seed funding in October 2024, led by Korea Investment Accelerator, to expand R&D and prepare for international growth.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in